Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
On-X Life Technologies Releases Expected Timelines for Reduced Anticoagulation Study Results at AATSSAN FRANCISCO, April 30, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is releasing the expected timelines for the initial submission to the FDA of...
-
News Highlights: Among findings posted in the inaugural publication of the American Heart Association's online-only, free-access scientific journal: The NIH Stroke Scale accurately identifies...
-
Study Highlights: In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin was similar to aspirin in preventing deaths and strokes in patients with heart...
-
Study Highlights: Combining the anti-blood clot medicine clopidogrel (Plavix) with aspirin is unlikely to prevent recurrent small subcortical strokes, which are caused by blood clots deep in...